_id
690da814ccc777a4e85d07bb
Ticker
ABCL
Name
Abcellera Biologics Inc
Exchange
NASDAQ
Address
150 West 4th Ave, Vancouver, BC, Canada, V5Y 1G6
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.abcellera.com
Description
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Last Close
4.15
Volume
2487934
Current Price
4.15
Change
-0.01
Last Updated
2026-01-21T18:40:47.365Z
Image
data:image/webp;base64,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
Ipo Date
2020-12-11T00:00:00.000Z
Market Cap
1245233664
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9964999999999999
Sentiment Sources
2
Rating
4.5556
Target Price
9.8333
Strong Buy
6
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
8955000
Cost Of Revenue
-
Gross Profit
8955000
Operating Expenses
85233000
Operating Income
-76278000
Interest Expense
-
Pretax Income
-45470001
Net Income
-57119000
Eps
-0.19111323043512474
Dividends Per Share
-
Shares Outstanding
299335048
Income Tax Expense
11648999
EBITDA
-40224001
Operating Margin
-851.7922948073701
Total Other Income Expense Net
30807999
Cash
108159000
Short Term Investments
412513000
Receivables
41456000
Inventories
-
Total Current Assets
695140000
Property Plant Equipment
427358000
Total Assets
1355992000
Payables
53117000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
391954000
Equity
964038000
Bs_currency_symbol
USD
Depreciation
7236000
Change In Working Capital
-18137000
Cash From Operations
-52594000
Capital Expenditures
8928000
Cash From Investing
36488000
Cash From Financing
7372000
Net Change In Cash
-9278000
Cf_currency_symbol
USD
PE
-
PB
1.2866007067148806
ROE
-5.924973911816754
ROA
-4.212340485784577
FCF
-61522000
Fcf Percent
-6.8701284198771635
Piotroski FScore
0
Health Score
34
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
6
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
8955000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
8955000
Quarters > 0 > income Statement > operating Expenses
85233000
Quarters > 0 > income Statement > operating Income
-76278000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-45470001
Quarters > 0 > income Statement > net Income
-57119000
Quarters > 0 > income Statement > eps
-0.19111323043512474
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
298875174
Quarters > 0 > income Statement > income Tax Expense
11648999
Quarters > 0 > income Statement > EBITDA
-40224001
Quarters > 0 > income Statement > operating Margin
-851.7922948073701
Quarters > 0 > income Statement > total Other Income Expense Net
30807999
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
108159000
Quarters > 0 > balance Sheet > short Term Investments
412513000
Quarters > 0 > balance Sheet > receivables
41456000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
695140000
Quarters > 0 > balance Sheet > property Plant Equipment
427358000
Quarters > 0 > balance Sheet > total Assets
1355992000
Quarters > 0 > balance Sheet > payables
53117000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
391954000
Quarters > 0 > balance Sheet > equity
964038000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-57119000
Quarters > 0 > cash Flow > depreciation
7236000
Quarters > 0 > cash Flow > change In Working Capital
-18137000
Quarters > 0 > cash Flow > cash From Operations
-52594000
Quarters > 0 > cash Flow > capital Expenditures
8928000
Quarters > 0 > cash Flow > cash From Investing
36488000
Quarters > 0 > cash Flow > cash From Financing
7372000
Quarters > 0 > cash Flow > net Change In Cash
-9278000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.19111323043512474
Quarters > 0 > ratios > PB
1.2866007067148806
Quarters > 0 > ratios > ROE
-5.924973911816754
Quarters > 0 > ratios > ROA
-4.212340485784577
Quarters > 0 > ratios > FCF
-61522000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-6.8701284198771635
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
17084000
Quarters > 1 > income Statement > cost Of Revenue
7059000
Quarters > 1 > income Statement > gross Profit
10025000
Quarters > 1 > income Statement > operating Expenses
59610000
Quarters > 1 > income Statement > operating Income
-49585000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-36344000
Quarters > 1 > income Statement > net Income
-34727000
Quarters > 1 > income Statement > eps
-0.11633500637390344
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
298508601
Quarters > 1 > income Statement > income Tax Expense
-1617000
Quarters > 1 > income Statement > EBITDA
-38833000
Quarters > 1 > income Statement > operating Margin
-290.24233200655584
Quarters > 1 > income Statement > total Other Income Expense Net
13241000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
92437000
Quarters > 1 > balance Sheet > short Term Investments
460641000
Quarters > 1 > balance Sheet > receivables
153367000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
742145000
Quarters > 1 > balance Sheet > property Plant Equipment
424020000
Quarters > 1 > balance Sheet > total Assets
1402061000
Quarters > 1 > balance Sheet > payables
32041000
Quarters > 1 > balance Sheet > short Term Debt
4896000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
394985000
Quarters > 1 > balance Sheet > equity
1007076000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-34727000
Quarters > 1 > cash Flow > depreciation
7060000
Quarters > 1 > cash Flow > change In Working Capital
-16801000
Quarters > 1 > cash Flow > cash From Operations
-32404000
Quarters > 1 > cash Flow > capital Expenditures
13365000
Quarters > 1 > cash Flow > cash From Investing
-31811000
Quarters > 1 > cash Flow > cash From Financing
-3375000
Quarters > 1 > cash Flow > net Change In Cash
-66829000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.11633500637390344
Quarters > 1 > ratios > PB
1.2301064608331447
Quarters > 1 > ratios > ROE
-3.4482998304000887
Quarters > 1 > ratios > ROA
-2.476853717491607
Quarters > 1 > ratios > FCF
-45769000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-2.6790564270662607
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
4235000
Quarters > 2 > income Statement > cost Of Revenue
42496000
Quarters > 2 > income Statement > gross Profit
4235000
Quarters > 2 > income Statement > operating Expenses
66895000
Quarters > 2 > income Statement > operating Income
-62660000
Quarters > 2 > income Statement > interest Expense
8051000
Quarters > 2 > income Statement > pretax Income
-52984000
Quarters > 2 > income Statement > net Income
-45621000
Quarters > 2 > income Statement > eps
-0.15324865430089554
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
297692663
Quarters > 2 > income Statement > income Tax Expense
-7363000
Quarters > 2 > income Statement > EBITDA
-51902000
Quarters > 2 > income Statement > operating Margin
-1479.5749704840614
Quarters > 2 > income Statement > total Other Income Expense Net
9676000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
159266000
Quarters > 2 > balance Sheet > short Term Investments
446000000
Quarters > 2 > balance Sheet > receivables
126614000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
764978000
Quarters > 2 > balance Sheet > property Plant Equipment
347102000
Quarters > 2 > balance Sheet > total Assets
1344208000
Quarters > 2 > balance Sheet > payables
32804000
Quarters > 2 > balance Sheet > short Term Debt
4637000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
321226000
Quarters > 2 > balance Sheet > equity
1022982000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-45621000
Quarters > 2 > cash Flow > depreciation
6605000
Quarters > 2 > cash Flow > change In Working Capital
10463000
Quarters > 2 > cash Flow > cash From Operations
-11554000
Quarters > 2 > cash Flow > capital Expenditures
10636000
Quarters > 2 > cash Flow > cash From Investing
7935000
Quarters > 2 > cash Flow > cash From Financing
5970000
Quarters > 2 > cash Flow > net Change In Cash
2941000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.15324865430089554
Quarters > 2 > ratios > PB
1.2076698822168914
Quarters > 2 > ratios > ROE
-4.459609259986979
Quarters > 2 > ratios > ROA
-3.393894397295657
Quarters > 2 > ratios > FCF
-22190000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-5.239669421487603
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
5050000
Quarters > 3 > income Statement > cost Of Revenue
13901000
Quarters > 3 > income Statement > gross Profit
5050000
Quarters > 3 > income Statement > operating Expenses
77805000
Quarters > 3 > income Statement > operating Income
-72755000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-46829000
Quarters > 3 > income Statement > net Income
-34210000
Quarters > 3 > income Statement > eps
-0.11612760212262518
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
294589739
Quarters > 3 > income Statement > income Tax Expense
-12619000
Quarters > 3 > income Statement > EBITDA
-55311000
Quarters > 3 > income Statement > operating Margin
-1440.6930693069307
Quarters > 3 > income Statement > total Other Income Expense Net
25926000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
156325000
Quarters > 3 > balance Sheet > short Term Investments
469289000
Quarters > 3 > balance Sheet > receivables
92130000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
751370000
Quarters > 3 > balance Sheet > property Plant Equipment
340429000
Quarters > 3 > balance Sheet > total Assets
1360553000
Quarters > 3 > balance Sheet > payables
34350000
Quarters > 3 > balance Sheet > short Term Debt
4621000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
304469000
Quarters > 3 > balance Sheet > equity
1056084000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-34210000
Quarters > 3 > cash Flow > depreciation
-18100000
Quarters > 3 > cash Flow > change In Working Capital
-15915000
Quarters > 3 > cash Flow > cash From Operations
-8000000
Quarters > 3 > cash Flow > capital Expenditures
15630000
Quarters > 3 > cash Flow > cash From Investing
35703000
Quarters > 3 > cash Flow > cash From Financing
4142000
Quarters > 3 > cash Flow > net Change In Cash
29685000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.11612760212262518
Quarters > 3 > ratios > PB
1.1576232731960716
Quarters > 3 > ratios > ROE
-3.2393256597013114
Quarters > 3 > ratios > ROA
-2.514418769426843
Quarters > 3 > ratios > FCF
-23630000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-4.679207920792079
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
28833000
Annuals > 0 > income Statement > cost Of Revenue
96999000
Annuals > 0 > income Statement > gross Profit
28833000
Annuals > 0 > income Statement > operating Expenses
343599000
Annuals > 0 > income Statement > operating Income
-314766000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-200395000
Annuals > 0 > income Statement > net Income
-162857000
Annuals > 0 > income Statement > eps
-0.5533189467304065
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
294327532
Annuals > 0 > income Statement > income Tax Expense
-37538000
Annuals > 0 > income Statement > EBITDA
-204148000
Annuals > 0 > income Statement > operating Margin
-1091.6866090937467
Annuals > 0 > income Statement > total Other Income Expense Net
114371000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
156325000
Annuals > 0 > balance Sheet > short Term Investments
469289000
Annuals > 0 > balance Sheet > receivables
92130000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
751370000
Annuals > 0 > balance Sheet > property Plant Equipment
340429000
Annuals > 0 > balance Sheet > total Assets
1360553000
Annuals > 0 > balance Sheet > payables
34350000
Annuals > 0 > balance Sheet > short Term Debt
4621000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
304469000
Annuals > 0 > balance Sheet > equity
1056084000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-162857000
Annuals > 0 > cash Flow > depreciation
96998000
Annuals > 0 > cash Flow > change In Working Capital
-25843000
Annuals > 0 > cash Flow > cash From Operations
-108556000
Annuals > 0 > cash Flow > capital Expenditures
78396000
Annuals > 0 > cash Flow > cash From Investing
121409000
Annuals > 0 > cash Flow > cash From Financing
12769000
Annuals > 0 > cash Flow > net Change In Cash
23005000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.5533189467304065
Annuals > 0 > ratios > PB
1.1565929015116223
Annuals > 0 > ratios > ROE
-15.420837736392182
Annuals > 0 > ratios > ROA
-11.96991223421653
Annuals > 0 > ratios > FCF
-186952000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-6.483959352131238
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
38025000
Annuals > 1 > income Statement > cost Of Revenue
30894000
Annuals > 1 > income Statement > gross Profit
38025000
Annuals > 1 > income Statement > operating Expenses
275232000
Annuals > 1 > income Statement > operating Income
-237207000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-174029000
Annuals > 1 > income Statement > net Income
-146398000
Annuals > 1 > income Statement > eps
-0.5062758206357288
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
289166486
Annuals > 1 > income Statement > income Tax Expense
-27631000
Annuals > 1 > income Statement > EBITDA
-192158000
Annuals > 1 > income Statement > operating Margin
-623.818540433925
Annuals > 1 > income Statement > total Other Income Expense Net
63178000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
133320000
Annuals > 1 > balance Sheet > short Term Investments
627265000
Annuals > 1 > balance Sheet > receivables
64382000
Annuals > 1 > balance Sheet > inventories
1107000
Annuals > 1 > balance Sheet > total Current Assets
871985000
Annuals > 1 > balance Sheet > property Plant Equipment
287696000
Annuals > 1 > balance Sheet > total Assets
1488094000
Annuals > 1 > balance Sheet > payables
25509000
Annuals > 1 > balance Sheet > short Term Debt
6158000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
335776000
Annuals > 1 > balance Sheet > equity
1152318000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-146398000
Annuals > 1 > cash Flow > depreciation
30894000
Annuals > 1 > cash Flow > change In Working Capital
13225000
Annuals > 1 > cash Flow > cash From Operations
-43877000
Annuals > 1 > cash Flow > capital Expenditures
77507000
Annuals > 1 > cash Flow > cash From Investing
-221108000
Annuals > 1 > cash Flow > cash From Financing
10356000
Annuals > 1 > cash Flow > net Change In Cash
-254040000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.5062758206357288
Annuals > 1 > ratios > PB
1.0414147109565244
Annuals > 1 > ratios > ROE
-12.704652708714088
Annuals > 1 > ratios > ROA
-9.837953785177548
Annuals > 1 > ratios > FCF
-121384000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-3.1922156476002628
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
485424000
Annuals > 2 > income Statement > cost Of Revenue
66436000
Annuals > 2 > income Statement > gross Profit
418988000
Annuals > 2 > income Statement > operating Expenses
202477000
Annuals > 2 > income Statement > operating Income
216511000
Annuals > 2 > income Statement > interest Expense
4045000
Annuals > 2 > income Statement > pretax Income
239099000
Annuals > 2 > income Statement > net Income
158519000
Annuals > 2 > income Statement > eps
0.503511044493273
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
314827255
Annuals > 2 > income Statement > income Tax Expense
80580000
Annuals > 2 > income Statement > EBITDA
260167000
Annuals > 2 > income Statement > operating Margin
44.60245064108903
Annuals > 2 > income Statement > total Other Income Expense Net
22588000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
386535000
Annuals > 2 > balance Sheet > short Term Investments
499950000
Annuals > 2 > balance Sheet > receivables
38593000
Annuals > 2 > balance Sheet > inventories
1532000
Annuals > 2 > balance Sheet > total Current Assets
1025491000
Annuals > 2 > balance Sheet > property Plant Equipment
217255000
Annuals > 2 > balance Sheet > total Assets
1540907000
Annuals > 2 > balance Sheet > payables
14828000
Annuals > 2 > balance Sheet > short Term Debt
5583000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
307630000
Annuals > 2 > balance Sheet > equity
1233277000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
158519000
Annuals > 2 > cash Flow > depreciation
33102000
Annuals > 2 > cash Flow > change In Working Capital
29825000
Annuals > 2 > cash Flow > cash From Operations
277360000
Annuals > 2 > cash Flow > capital Expenditures
72660000
Annuals > 2 > cash Flow > cash From Investing
-352625000
Annuals > 2 > cash Flow > cash From Financing
-1628000
Annuals > 2 > cash Flow > net Change In Cash
-86492000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.503511044493273
Annuals > 2 > ratios > PB
1.0593995576419573
Annuals > 2 > ratios > ROE
12.853478983229232
Annuals > 2 > ratios > ROA
10.287382690843769
Annuals > 2 > ratios > FCF
204700000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.42169320017139655
Annuals > 2 > health Score
89
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
11611543
Annuals > 3 > income Statement > cost Of Revenue
45516000
Annuals > 3 > income Statement > gross Profit
11611543
Annuals > 3 > income Statement > operating Expenses
13954056
Annuals > 3 > income Statement > operating Income
-4117008
Annuals > 3 > income Statement > interest Expense
209196
Annuals > 3 > income Statement > pretax Income
-2210696
Annuals > 3 > income Statement > net Income
-2210696
Annuals > 3 > income Statement > eps
-0.006945447796296255
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
318294236
Annuals > 3 > income Statement > income Tax Expense
65685000
Annuals > 3 > income Statement > EBITDA
-154612
Annuals > 3 > income Statement > operating Margin
-35.45616633379388
Annuals > 3 > income Statement > total Other Income Expense Net
1906312
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
476142000
Annuals > 3 > balance Sheet > short Term Investments
246835000
Annuals > 3 > balance Sheet > receivables
160576000
Annuals > 3 > balance Sheet > inventories
1672000
Annuals > 3 > balance Sheet > total Current Assets
929800000
Annuals > 3 > balance Sheet > property Plant Equipment
111616000
Annuals > 3 > balance Sheet > total Assets
1318569000
Annuals > 3 > balance Sheet > payables
14924000
Annuals > 3 > balance Sheet > short Term Debt
3652000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
292836000
Annuals > 3 > balance Sheet > equity
1025733000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
153464000
Annuals > 3 > cash Flow > depreciation
17250000
Annuals > 3 > cash Flow > change In Working Capital
41672000
Annuals > 3 > cash Flow > cash From Operations
244584000
Annuals > 3 > cash Flow > capital Expenditures
58452000
Annuals > 3 > cash Flow > cash From Investing
-332247000
Annuals > 3 > cash Flow > cash From Financing
-3886000
Annuals > 3 > cash Flow > net Change In Cash
-92974000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.006945447796296255
Annuals > 3 > ratios > PB
1.2877825705129895
Annuals > 3 > ratios > ROE
-0.21552353292718474
Annuals > 3 > ratios > ROA
-0.1676587269987388
Annuals > 3 > ratios > FCF
186132000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
16.02991092570557
Annuals > 3 > health Score
54
Valuation > metrics > PE
-0.19111323043512474
Valuation > metrics > PB
1.2866007067148806
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-5.924973911816754
Profitability > metrics > ROA
-8.216905947003482
Profitability > metrics > Net Margin
-6.3784477945281965
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4065752594814727
Risk > metrics > Interest Coverage
-14.540221120853984
Risk > final Score
2
Risk > verdict
High
Liquidity > metrics > Current Ratio
13.086958977351884
Liquidity > metrics > Quick Ratio
13.086958977351884
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-20
Prev Risks > 1
29
Prev Risks > 2
26
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-21T18:40:48.050Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-24
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.144
Earnings History > 0 > eps Difference
0.144
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.19
Earnings History > 1 > eps Estimate
-0.14
Earnings History > 1 > eps Difference
-0.05
Earnings History > 1 > surprise Percent
-35.7143
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.12
Earnings History > 2 > eps Estimate
-0.14
Earnings History > 2 > eps Difference
0.02
Earnings History > 2 > surprise Percent
14.2857
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-05
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.15
Earnings History > 3 > eps Estimate
-0.17
Earnings History > 3 > eps Difference
0.02
Earnings History > 3 > surprise Percent
11.7647
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-18
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.12
Earnings History > 4 > eps Estimate
-0.1471
Earnings History > 4 > eps Difference
0.0271
Earnings History > 4 > surprise Percent
18.4228
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-04
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.17
Earnings History > 5 > eps Estimate
-0.15
Earnings History > 5 > eps Difference
-0.02
Earnings History > 5 > surprise Percent
-13.3333
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.13
Earnings History > 6 > eps Estimate
-0.14
Earnings History > 6 > eps Difference
0.01
Earnings History > 6 > surprise Percent
7.1429
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-07
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.14
Earnings History > 7 > eps Estimate
-0.17
Earnings History > 7 > eps Difference
0.03
Earnings History > 7 > surprise Percent
17.6471
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-20
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.17
Earnings History > 8 > eps Estimate
-0.13
Earnings History > 8 > eps Difference
-0.04
Earnings History > 8 > surprise Percent
-30.7692
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-02
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.1
Earnings History > 9 > eps Estimate
-0.13
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
23.0769
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-03
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.11
Earnings History > 10 > eps Estimate
-0.13
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
15.3846
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-04
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.14
Earnings History > 11 > eps Estimate
-0.14
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-02-21
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.1
Earnings History > 12 > eps Estimate
-0.01
Earnings History > 12 > eps Difference
-0.09
Earnings History > 12 > surprise Percent
-900
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.08
Earnings History > 13 > eps Estimate
0.05
Earnings History > 13 > eps Difference
0.03
Earnings History > 13 > surprise Percent
60
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.02
Earnings History > 14 > eps Estimate
-0.02
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-10
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.54
Earnings History > 15 > eps Estimate
0.38
Earnings History > 15 > eps Difference
0.16
Earnings History > 15 > surprise Percent
42.1053
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-24
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.19
Earnings History > 16 > eps Estimate
0.19
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-09
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.08
Earnings History > 17 > eps Estimate
-0.05
Earnings History > 17 > eps Difference
-0.03
Earnings History > 17 > surprise Percent
-60
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-12
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.01
Earnings History > 18 > eps Estimate
0.08
Earnings History > 18 > eps Difference
-0.09
Earnings History > 18 > surprise Percent
-112.5
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-13
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.37
Earnings History > 19 > eps Estimate
0.38
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-2.6316
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-29
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.44
Earnings History > 20 > eps Estimate
0.61
Earnings History > 20 > eps Difference
-0.17
Earnings History > 20 > surprise Percent
-27.8689
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-12-14
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.04
Earnings History > 21 > eps Estimate
-0.02
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-100
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0134
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-30
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0.0102
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.0102
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2020-03-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
0.0102
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0.0102
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-12-31
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0108
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0108
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-09-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
0.0002
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0.0002
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-06-30
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.002
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.002
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2019-03-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.002
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.002
Earnings History > 28 > surprise Percent
-
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAbCellera Biologics (NASDAQ:ABCL) Stock Rating Lowered by Wall Street Zen MarketBeat
Read more →Is AbCellera (ABCL) Quietly Recasting Its Platform As A Menopause-Focused Drug Developer? simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$9.8333
Analyst Picks
Strong Buy
6
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 46.52% of the total shares of Abcellera Biologics Inc
1.
Baker Bros Advisors LP(9.211%)
since
2025/06/30
2.
Capital World Investors(4.4711%)
since
2025/06/30
3.
American Funds SMALLCAP World A(4.4711%)
since
2025/06/30
4.
Baillie Gifford & Co Limited.(3.4668%)
since
2025/06/30
5.
UBS Asset Mgmt Americas Inc(2.8349%)
since
2025/06/30
6.
SMDS Global AI Equity Mother(1.5027%)
since
2025/03/25
7.
Two Sigma Investments LLC(1.3756%)
since
2025/06/30
8.
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)(1.3737%)
since
2025/06/30
9.
Two Sigma Advisers, LLC(1.3621%)
since
2025/06/30
10.
Baillie Gifford Positive Change B Acc(1.3008%)
since
2025/07/31
11.
Baillie Gifford Positive Change(1.3008%)
since
2025/07/31
12.
BlackRock Inc(1.2317%)
since
2025/06/30
13.
UBS Group AG(1.1538%)
since
2025/06/30
14.
UBS Lux Dgtl Hlth Eq Fd seeding P acc(1.1385%)
since
2025/07/31
15.
Millennium Management LLC(1.137%)
since
2025/06/30
16.
Orbimed Advisors, LLC(1.1192%)
since
2025/06/30
17.
Renaissance Technologies Corp(1.1068%)
since
2025/06/30
18.
Citadel Advisors Llc(0.967%)
since
2025/06/30
19.
TANG CAPITAL MANAGEMENT LLC(0.8701%)
since
2025/06/30
20.
Baillie Gifford WW Pstv Chg B USD Acc(0.755%)
since
2025/07/31
21.
ACATIS Datini Valueflex Fonds A(0.6224%)
since
2025/07/31
22.
Guardian Partners Inc.(0.5978%)
since
2025/06/30
23.
iShares Biotechnology ETF(0.4486%)
since
2025/08/31
24.
Morgan Stanley - Brokerage Accounts(0.3336%)
since
2025/06/30
25.
Novo A/S(0.2184%)
since
2025/06/30
26.
NORGES BANK(0.2111%)
since
2025/06/30
27.
State Street Corp(0.2056%)
since
2025/06/30
28.
Susquehanna International Group, LLP(0.1989%)
since
2025/06/30
29.
iShares Genomics Immnlgy & Hlthcr ETF(0.1867%)
since
2025/08/31
30.
SPDR® Portfolio Developed Wld ex-US ETF(0.167%)
since
2025/08/29
31.
Lazard Digital Health(0.1589%)
since
2025/06/30
32.
Baillie Gifford Positive Chg CI FD Cl E(0.1545%)
since
2025/06/30
33.
Keystone Positive Change Investment Ord(0.1352%)
since
2025/02/28
34.
Vanguard Baillie GiffordGlbPstvImpStkInv(0.1343%)
since
2025/06/30
35.
Desjardins Sustainable Positive Change F(0.1272%)
since
2025/08/31
36.
BlackRock Advantage Small Cap Core Instl(0.1161%)
since
2025/07/31
37.
SEB Artificial Intelligence D (USD)(0.1139%)
since
2025/07/31
38.
iShares Healthcare Innov ETF USD Acc(0.0869%)
since
2025/08/31
39.
Fidelity Nasdaq Composite ETF(0.0772%)
since
2025/08/29
40.
DNB Fund - Disruptive Opp Retail A EUR(0.0744%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.144
Date
2025-09-30
EPS Actual
-0.19
EPS Estimate
-0.14
EPS Difference
-0.05
Surprise Percent
-35.7143%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.